Individuals with known hypersensitivity to any of the ingredients.
Should be used with medical advice during Pregnancy & Lactation.
Hemochromatosis and hemosiderosis are contraindicated to iron therapy.
Folic acid is contraindicated in patients with pernicious anemia.
Folic acid should not be prescribed until the diagnosis of pernicious anemia has been eliminated, since it can alleviate hematologic manifestations while allowing neurological damages to continue undetected.
Cyanocobalamin should, if possible, not be given to patients without confirming first the diagnosis, and should not be used to treat megaloblastic anemia of pregnancy. Administration of doses greater than 10 mcg daily may produce a hematological response in patients with folate deficiency; indiscriminate use may mask precise diagnosis.